Chad Robins - CEO and Chairman, Adaptive Biotechnologies Corp

As of September 10, 2021


Chad Robins Net Worth

  • Net worth is estimated to be at least $101.07M
  • Owns at least 1,673,461 units of Adaptive Biotechnologies Corp stock
  • Sold an estimated value of $8.4M in the last 8 months at Adaptive Biotechnologies Corp

Chad Robins Compensation at Adaptive Biotechnologies Corp in 2020

  • Earned a $493,750 salary
  • Received a total compensation of $6,761,270

Chad Robins Trading

  • Largest sale of shares was 30,000 units , worth over $1.87M on February 10, 2021
  • In total has made about 9 transactions over 8 months
  • Usually trades in January and March, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Chad Robins Mailing Address

  • Mailing address is C/o Adaptive Biotechnologies Corporation 1551 Eastlake Ave E Ste 200 Seattle WA 98102 WA

Adaptive Biotechnologies Corp Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Chad Robins 2020 $597,400 - $500,000 $500,000 $20,098 $7,131,118
Chad Robins 2019 $492,555 - $385,950 $385,950 - $2,856,181
Chad Robins 2018 $422,815 - $266,500 $266,500 - $3,194,658
Chad Cohen 2020 $411,950 - $210,000 $210,000 $3,943 $2,329,752
Chad Cohen 2019 $381,413 - $193,900 $193,900 - $1,130,027
Chad Cohen 2018 $359,188 - $158,500 $158,500 - $1,144,024
Harlan Robins, PhD 2020 $493,750 - $250,000 $250,000 $3,900 $6,761,270
Harlan Robins, PhD 2019 $431,846 - $237,500 $237,500 - $2,647,022
Harlan Robins, PhD 2018 $348,938 - $158,500 $158,500 - $2,177,666
Harlan Robins, PhD 2020 $481,100 - $250,000 $250,000 $3,675 $4,743,855
Harlan Robins, PhD 2019 $412,050 - $212,200 $212,200 - $1,709,560
Harlan Robins, PhD 2018 $368,753 - $187,500 $187,500 - $2,226,481
Harlan Robins, PhD 2020 $280,859 $1,405,000 $112,022 $112,022 $10,523 $2,699,999
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1478320/000156459021020371/adpt-def14a_20210611.htm

Adaptive Biotechnologies Corp Insider Trading

  • The most recent transaction was 11,685 units sold on September 15, 2021 by Harlan Robins worth over $432.05K
  • In the last 12 years, insiders at Adaptive Biotechnologies Corp sold an estimated value of $1.27B and bought an estimated value of $142.1M
  • The most active traders are Steel Partners Holdings Lp,  Steel Partners Llc,  and Warren Lichtenstein, President Subsidiary
  • Insider trading is most common in February, with the busiest year in 2020

Adeptus Health Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1